long-chain fatty acid oxidation disorders

Ultragenyx Pharma Wins FDA’s First Drug Nod for Rare Metabolic Disorder
Xconomy
Tue, 06/30/20 - 11:35 pm
Ultragenyx
FDA
long-chain fatty acid oxidation disorders
Dojolvi